Moss, AlastairDaghem, MarwaTzolos, EvangelosMeah, Mohammed NWang, Kang-LingBularga, AndaAdamson, Philip DKwiecinski, JacekFletcher, AlisonDawson, DanaArumugam, ParthibanSabharwal, NikantGreenwood, John PTownend, Jon NCalvert, Patrick ARudd, James H FBerman, DanVerjans, JohanSlomka, PiotrDey, DaminiForsyth, LauraMurdoch, LaurenLee, Robert JLewis, SteffMills, Nicholas Lvan Beek, Edwin J RWilliams, Michelle CDweck, Marc RNewby, David EPREFFIR Investigators2023-08-012023-08-012023-08-01Moss, A, Daghem, M, Tzolos, E, Meah, M N, Wang, K-L, Bularga, A, Adamson, P D, Kwiecinski, J, Fletcher, A, Dawson, D, Arumugam, P, Sabharwal, N, Greenwood, J P, Townend, J N, Calvert, P A, Rudd, J H F, Berman, D, Verjans, J, Slomka, P, Dey, D, Forsyth, L, Murdoch, L, Lee, R J, Lewis, S, Mills, N L, van Beek, E J R, Williams, M C, Dweck, M R, Newby, D E & PREFFIR Investigators 2023, 'Coronary Atherosclerotic Plaque Activity and Future Coronary Events', JAMA cardiology, vol. 8, no. 8, pp. 755-764. https://doi.org/10.1001/jamacardio.2023.17292380-6591PubMedCentral: PMC10308296unpaywall: 10.1001/jamacardio.2023.1729ORCID: /0000-0003-2815-4469/work/160846775https://hdl.handle.net/2164/21338This study was funded by a Wellcome Trust Senior Investigator Award (WT103782AIA). Image analysis was supported by National Institutes for Health (R34HL161195 and 1R01HL135557). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Wellcome Trust or the National Institutes of Health. The British Heart Foundation supports DEN (CH/09/002, RG/16/10/32375, RE/18/5/34216), MRD (FS/SCRF/21/32010), NLM (CH/F/21/90010, RG/20/10/34966, RE/18/5/34216) AJM (AA/18/3/34220) and MCW (FS/ICRF/20/26002) and DD (FS/RTF/20/30009, NH/19/1/34595, PG/18/35/33786, PG/15/88/31780, PG/17/64/33205). MRD is the recipient of the Sir Jules Thorn Award for Biomedical Research 2015 (15/JTA). PJS is supported by outstanding investigator award National Institutes for Health (R35HL161195). JK is supported by the National Science Centre 2021/41/B/NZ5/02630. EvB is supported by SINAPSE (www.sinapse.ac.uk). AB is supported by a Clinical Research Training Fellowships (MR/V007254/1). DD is supported by Chest Heart and Stroke Scotland (19/53), Tenovus Scotland (G.18.01), and Friends of Anchor and Grampian NHS-Endowments. The Edinburgh Clinical Research Facilities, Edinburgh Imaging facility and Edinburgh Clinical Trials Unit are supported by the National Health Service Research Scotland through National Health Service Lothian Health Board. The Leeds Clinical Research Facilities are supported by the UK National Institute for Health Research (NIHR) via its Clinical Research Facility programme. The work at Cedars-Sinai Medical Center (the Los Angeles site) was supported in part by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. For the purpose of open access, the author has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission. The Chief Investigator and Edinburgh Clinical Trials Unit had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.10300067engR MedicineWellcome TrustWT103782AIABritish Heart FoundationCH/09/002RG/16/10/32375RE/18/5/34216FS/SCRF/21/32010CH/F/21/90010RG/20/10/34966AA/18/3/34220FS/ICRF/20/26002FS/RTF/20/30009NH/19/1/34595PG/18/35/33786PG/15/88/31780PG/17/64/33205National Institute for Health Research (NIHR)RJournal article10.1001/jamacardio.2023.1729http://www.scopus.com/inward/record.url?scp=85167479821&partnerID=8YFLogxK88